Stanford, CA, United States of America

Paul Khavari

This inventor holds 1 USPTO granted patent. Top assignee: Maxygen, Inc.. Active years: 2002.


% Patents Active = 100.0

Average Co-Inventor Count = 3.0

ph-index = 1

Forward Citations = 34(Granted Patents)


Company Filing History:


Years Active: 2002

Loading Chart...
1 patent (USPTO):Explore Patents

Title: Paul Khavari: Innovator in Gene Therapy

Introduction

Paul Khavari is a notable inventor based in Stanford, CA (US). He has made significant contributions to the field of gene therapy, particularly through his work on human papillomavirus vectors. His innovative approach has the potential to impact various medical applications.

Latest Patents

Khavari holds a patent for "Human papilloma virus vectors." This invention provides human papillomavirus vectors that are useful in gene therapy. The vectors contain E1 and E2 coding regions from a benign or low-risk human papillomavirus, operably linked to a promoter and enhancer. Additionally, the vectors include an LCR region from a human papillomavirus, which comprises an origin of replication with binding sites for the E1 and E2 proteins. The invention also outlines methods for using these vectors in gene therapy, controlling expression with a patch, and evolving drugs for stimulating hair growth or altering hair color. He has 1 patent to his name.

Career Highlights

Khavari is associated with Maxygen, Inc., where he continues to advance his research and innovations. His work has garnered attention in the scientific community for its potential applications in gene therapy and beyond.

Collaborations

He has collaborated with notable colleagues, including Doris Apt and William P C Stemmer, who have contributed to his research endeavors.

Conclusion

Paul Khavari's contributions to gene therapy through his innovative patent on human papillomavirus vectors highlight his role as a significant inventor in the field. His work continues to pave the way for advancements in medical treatments and therapies.

This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to [email protected]
Loading…